VANESSA BERRIOS: Open Payments
NPI 1982977096 · ST. JOHNS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,446 in 74 payments from 17 companies in 2025. Trend: 2023 $1,259 · 2024 $1,448 · 2025 $1,446
Food & beverage: $1,446
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $193 |
| Novo Nordisk Inc | 13 | $185 |
| Amgen Inc. | 6 | $156 |
| ABBVIE INC. | 8 | $144 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $143 |
| Otsuka America Pharmaceutical, Inc. | 5 | $107 |
| Daiichi Sankyo Inc. | 3 | $80 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Lilly USA, LLC | 3 | $61 |
Products named: Kerendia, REXULTI, REPATHA, Wegovy, ELIQUIS, INJECTAFER, NURTEC ODT, VRAYLAR.
Industry payments across FL — which companies pay providers there.
